ARCHIVES

Imbruvica Improves PFS, OS In Phase III CLL Study

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Programs: Director Challenges Scientists To Develop Molecular “Fingerprints” Of Tumors

December 4, 1998

Groups Have No Budgets As NCTN Begins Work March 1

February 28, 2014

Healthy Weight, Lower Stress May Result In Fewer Changes Associated With Aging

March 27, 2009

FDA Approves Avastin Combination For Late-Stage Cervical Cancer

August 29, 2014

“NIH Reveres, Honors, respects And Defends One And Only One Mechanisms’ – R01s

September 20, 1991

Two Doses of the Vaccine Cervarix Can Be As Effective As Three

September 30, 2011